| Robert C Candipan, MD | |
|
7529 E Broadway Rd Ste 101, Mesa, AZ 85208-2007 | |
| (480) 945-4343 | |
| (480) 945-4350 |
| Full Name | Robert C Candipan |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 37 Years |
| Location | 7529 E Broadway Rd Ste 101, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457375529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 40722 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiojost Inc | 2062429913 | 12 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Yavapai Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902897820 PECOS PAC ID: 6608777024 Enrollment ID: O20040119000405 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Heart & Vascular Center Of Arizona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255379541 PECOS PAC ID: 3870487812 Enrollment ID: O20040211000448 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Cardiojost Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023122843 PECOS PAC ID: 2062429913 Enrollment ID: O20060317000050 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Honorhealth Ambulatory |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Yavapai Regional Medical Center Physician Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255582003 PECOS PAC ID: 5294898987 Enrollment ID: O20090106000798 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Southwest Cardiovascular Interventional Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1588203723 PECOS PAC ID: 8224458443 Enrollment ID: O20201008003040 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Entity Name | Exceptional Physician Group Arizona, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447910229 PECOS PAC ID: 0042605008 Enrollment ID: O20220310000502 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert C Candipan, MD 5416 E Baseline Rd Ste 129, Mesa, AZ 85206-4703 Ph: (480) 945-4343 | Robert C Candipan, MD 7529 E Broadway Rd Ste 101, Mesa, AZ 85208-2007 Ph: (480) 945-4343 |
News Archive
People who have a high body mass index or who gain weight as they get older may have a lower risk of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, according to a large study published in the June 26, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.
New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites - the filament-like projections that conduct electrochemical signals between neurons - and disrupts normal patterns of neuronal connections in the brain.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.
› Verified 4 days ago
Dr. Emmanuel A Bayongan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |